The high-affinity CB1R agonist WIN 55,212-2 was also able to relieve mechanical allodynia (i.e., pain sensation) when applied to in vivo rat models of both type 1 and type 2 diabetes (133). The gene discussed is CNR1; the disease is type 2 diabetes mellitus.